211 related articles for article (PubMed ID: 17499541)
21. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
[TBL] [Abstract][Full Text] [Related]
22. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.
Cederholm J; Eliasson B; Nilsson PM; Weiss L; Gudbjörnsdottir S;
Diabetes Res Clin Pract; 2005 Mar; 67(3):258-66. PubMed ID: 15713359
[TBL] [Abstract][Full Text] [Related]
23. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
[TBL] [Abstract][Full Text] [Related]
24. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
25. Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony.
Berg AH; Sacks DB
J Clin Pathol; 2008 Sep; 61(9):983-7. PubMed ID: 18755722
[TBL] [Abstract][Full Text] [Related]
26. The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study.
Calvert MJ; McManus RJ; Freemantle N
Fam Pract; 2007 Jun; 24(3):224-9. PubMed ID: 17488736
[TBL] [Abstract][Full Text] [Related]
27. PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort.
Lüddeke HJ; Sreenan S; Aczel S; Maxeiner S; Yenigun M; Kozlovski P; Gydesen H; Dornhorst A;
Diabetes Obes Metab; 2007 May; 9(3):428-34. PubMed ID: 17391171
[TBL] [Abstract][Full Text] [Related]
28. Glycaemic control, disease duration and beta-cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project.
Ostgren CJ; Lindblad U; Ranstam J; Melander A; Råstam L;
Diabet Med; 2002 Feb; 19(2):125-9. PubMed ID: 11874428
[TBL] [Abstract][Full Text] [Related]
29. Inequalities in glycaemic control in patients with Type 2 diabetes in primary care.
Bebb C; Kendrick D; Stewart J; Coupland C; Madeley R; Brown K; Burden R; Sturrock N
Diabet Med; 2005 Oct; 22(10):1364-71. PubMed ID: 16176198
[TBL] [Abstract][Full Text] [Related]
30. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
31. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
[TBL] [Abstract][Full Text] [Related]
32. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.
Khan HA; Sobki SH; Khan SA
Clin Exp Med; 2007 Mar; 7(1):24-9. PubMed ID: 17380302
[TBL] [Abstract][Full Text] [Related]
33. Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age.
Nagrebetsky A; Griffin S; Kinmonth AL; Sutton S; Craven A; Farmer A
Diabetes Res Clin Pract; 2012 May; 96(2):119-28. PubMed ID: 22261095
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
Müller N; Kloos C; Frank T; Ristow M; Wolf G; Müller UA
Diabet Med; 2011 Feb; 28(2):223-6. PubMed ID: 21219434
[TBL] [Abstract][Full Text] [Related]
35. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
37. The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments.
Vischer UM; Perrenoud L; Genet C; Ardigo S; Registe-Rameau Y; Herrmann FR
Diabet Med; 2010 Aug; 27(8):918-24. PubMed ID: 20653750
[TBL] [Abstract][Full Text] [Related]
38. The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practice.
Schreiber SA; Ferlinz K; Haak T
Diabetes Technol Ther; 2008 Apr; 10(2):121-7. PubMed ID: 18260775
[TBL] [Abstract][Full Text] [Related]
39. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A
BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919
[TBL] [Abstract][Full Text] [Related]
40. [Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].
Perusicová J; Haladová I; Pit'hová P; Acsová D; Belobrádková J; Belzová A; Berková K; Dolezalová B; Dvoráková H; Hejnicová K; Hudcová M; Kallmünzerová D; Krejsová Z; Markofová G; Müllerová H; Owen K; Pelikánová M; Raclavská L; Racická E; Skarpová O; Váchová A; Veselá A; Vyoralos J; Broz J; Edelsberger T; Honka M; Hrdina T; Chmura P; Tosovský J
Vnitr Lek; 2013 Mar; 59(3):165-71. PubMed ID: 23713182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
